((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt

Catalog No. :
ACSKGS804
CAS No. :
36051-69-1
Molecular Formula :
C9H11N2Na2O15P3-2
Molecular Weight :
526.09

IUPAC Name:disodium mono((2R,3R,4S,5R)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-5-(((hydroxy((((hydroxyoxidophosphoryl)oxy)oxidophosphoryl)oxy)phosphoryl)oxy)methyl)tetrahydrofuran-3,4-bis(olate))

((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, disodium salt
IUPAC Namedisodium mono((2R,3R,4S,5R)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-5-(((hydroxy((((hydroxyoxidophosphoryl)oxy)oxidophosphoryl)oxy)phosphoryl)oxy)methyl)tetrahydrofuran-3,4-bis(olate))
Molecular FormulaC9H11N2Na2O15P3-2
Molecular Weight526.09
SMILESO=C1C=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)([O-])OP(=O)([O-])O)[C@@H]([O-])[C@H]2[O-])C(=O)N1.[Na+].[Na+]
InChI KeyVAUFPLJRQFWTKJ-WFIJOQBCSA-L
SynonymUridine 5'-(tetrahydrogen triphosphate), sodium salt (1:2);Uridine 5'-triphosphate disodium
CAS No.36051-69-1

Synthetic Route by SureRoute

1. ACSKGS804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSKGS804 route product structure diagram
    ACSKGS80436051-69-1
Inquiry

2. ACSKGS804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSKGS804 route product structure diagram
    ACSKGS80436051-69-1
Inquiry

Comments (0)